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Developmental programming is the process whereby the environment before birth and in early 
neonatal life influences the structure and function of developing physiological systems with long 
lasting consequences for health in adult life.  When the concept of developmental programming and 
the ‘Developmental Origins of Health and Disease’ was first proposed, the hypothesis focused on the 
effects of a low nutrient environment on offspring physiology (Barker, 2004).  Epidemiological data 
showed that term infants born small were more likely to suffer from metabolic and cardiovascular 
disease in adult life, including type II diabetes, non-alcoholic fatty liver disease (NAFLD) and coronary 
heart disease, compared to those born of average weight.  The fetus exposed to under-nutrition 
appears to develop a ‘thrifty phenotype’ which is beneficial for survival in the short term, but which 
predisposes the offspring to metabolic and cardiovascular dysfunction in later life. 
More recently, attention has turned to the consequences of maternal over-nutrition which has 
become an increasing concern in the developed world.  In the UK, approximately 50% of women of 
reproductive age are overweight or obese, and 1 in 5 women are obese during pregnancy.  The 
effects of over-nutrition during pregnancy have been examined in a wide range of epidemiological, 
clinical and experimental animal studies (Glastras et al, 2018).  Maternal obesity has been shown to 
impact the development of the placenta, early embryo and fetus with consequences for the 
offspring in the short and longer term.  Higher incidences of both growth restriction and macrosomia 
are observed in babies born to obese mothers, and these infants at opposite ends of the birth 
weight spectrum are at greater risk of metabolic and cardiovascular dysfunction in later life.  
Interestingly, there are similar long term outcomes in human and animal offspring that were 
exposed to either maternal under- or over-nutrition before birth, both sub-optimal environments for 
normal growth and development.   
A variety of interacting mechanisms may be involved in developmental programming by maternal 
obesity, including exposure to maternal metabolites and adipose-derived cytokines with epigenetic 
and other effects.  Maternal obesity is associated with elevated systemic and tissue levels of 
inflammatory factors, and markers of inflammation, oxidative stress and endothelial dysfunction in 
the placenta.  In this issue, Lomas-Soria and colleagues have examined the mechanisms that may be 
responsible for hepatic dysfunction and NAFLD in the offspring of a rat model of maternal obesity 
(Lomas-Soria et al, 2018).  Rats were fed a high fat, obesogenic diet from weaning and during 
pregnancy and lactation.  The young adult offspring were hyperinsulinaemic and 
hypertriglyceridaemic, and showed greater body adiposity and hepatic triglyceride content than the 
offspring of dams fed the control diet.  More marked changes in liver enlargement, histology and fat 
content were observed in the male compared to female offspring.  The study also provides 
important information on underlying molecular changes to complement the findings in the fetuses 
of non-human primates fed a high fat diet during pregnancy (McCurdy et al, 2009).  In the fetal liver, 
early signs of NAFLD were characterised by increased triglyceride content, oxidative stress and 
activation of gluconeogenic pathways.  These changes were associated with high concentrations of 
inflammatory cytokines in the fetal circulation.  Taken together, these studies demonstrate that a 
maternal high fat diet influences hepatic development in the fetus with effects that persist into 
adulthood to increase the risk of NAFLD. 
Following bioinformatic analysis of the offspring liver transcriptome, Lomas-Soria et al (2018) report 
a number of differentially expressed genes in response to maternal obesity.  In male offspring, 1317 
genes were down-regulated compared to only 24 genes in the female offspring, and 40-50 genes 
were up-regulated in both sexes.  Many of the genes affected were related to insulin signalling, and 
glucose and lipid metabolism in the liver.  These findings highlight a range of new targets for future 
investigation.  Further studies are also required to determine whether these molecular changes are 
responsible for, or are secondary to, the developmental programming of hepatic dysfunction. 
Remarkably, only 1 common gene showed a consistent response to maternal obesity in both male 
and female offspring.  Therefore, in pregnancies complicated by maternal obesity, there may be 
differences in the sensitivity of male and female offspring to the intrauterine environment and/or 
separate molecular pathways in the subsequent programming of hepatic dysfunction.  The distinct 
profiles of responsive genes, and differences in hepatic phenotype observed between the sexes, also 
reinforce the importance of considering data from males and females separately.  Sexual 
dimorphism is a well-recognised feature of developmental programming (Dearden et al, 2018).  The 
mechanisms responsible for sex-dependent outcomes are unclear but differences in epigenetic 
processes within the placenta, hypothalamus and adipose tissue have been reported in experimental 
animal studies.   
The study by Lomas-Soria et al (2018) contributes to our understanding of developmental 
programming of hepatic function by maternal obesity and raises a number of important questions: 
What are the mechanisms that protect the female offspring from the adverse effects of maternal 
obesity on hepatic structure and function?  To what extent do the molecular changes observed in 
male offspring contribute to the ‘male disadvantage’ in morbidity, including NAFLD, and longevity?  
The alarming rates of NAFLD and type II diabetes, especially in children and adolescents, parallel the 
global epidemic in obesity, and this relationship may originate in early life.  Further research is vital 
to map the effects of the intrauterine environment on metabolic function, and the molecular 
mechanisms responsible, over the life course of an individual and to assess the potential of 
intervention strategies before and after birth. 
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